BARONE, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 177
EU - Europa 138
AS - Asia 110
SA - Sud America 13
AF - Africa 3
OC - Oceania 2
Totale 443
Nazione #
US - Stati Uniti d'America 173
SG - Singapore 74
IT - Italia 73
DE - Germania 23
CN - Cina 17
BR - Brasile 12
FI - Finlandia 7
GB - Regno Unito 7
SE - Svezia 7
IN - India 6
NL - Olanda 5
EE - Estonia 4
VN - Vietnam 4
FR - Francia 3
AT - Austria 2
CA - Canada 2
CZ - Repubblica Ceca 2
ES - Italia 2
ID - Indonesia 2
MX - Messico 2
NG - Nigeria 2
PK - Pakistan 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CO - Colombia 1
HK - Hong Kong 1
PL - Polonia 1
PS - Palestinian Territory 1
TR - Turchia 1
TV - Tuvalu 1
ZA - Sudafrica 1
Totale 443
Città #
Dallas 56
Singapore 41
Munich 18
Hefei 16
Santa Clara 14
Chandler 11
Milan 9
Rome 6
Boardman 5
London 5
Chicago 4
Florence 4
Lawrence 4
Misterbianco 4
Princeton 4
Taranto 4
West Lafayette 4
Ashburn 3
Benevento 3
Chennai 3
Cittanova 3
Los Angeles 3
Montecorice 3
San Nicola Manfredi 3
Turku 3
Abuja 2
Amantea 2
Augusta 2
Aversa 2
Bologna 2
Borgia 2
Boston 2
Casoria 2
Catanzaro 2
Helsinki 2
Lamezia Terme 2
Madrid 2
Morciano di Leuca 2
New York 2
Nuremberg 2
Olomouc 2
The Dalles 2
West Jordan 2
Wilmington 2
Amsterdam 1
Araguari 1
Arapiraca 1
Bari 1
Bekasi 1
Bitonto 1
Bra 1
Bắc Giang 1
Casca 1
Caserta 1
Columbia 1
Conceição do Araguaia 1
Cáceres 1
Céu Azul 1
Cúcuta 1
Dourados 1
Duncan 1
Düsseldorf 1
Frontenard 1
Funafuti 1
Hanoi 1
Ho Chi Minh City 1
Hong Kong 1
Jakarta 1
Johannesburg 1
Karachi 1
League City 1
Lucknow 1
Manchester 1
Multan 1
Naples 1
New Delhi 1
Newcastle upon Tyne 1
Norwalk 1
Nova Serrana 1
Oklahoma City 1
Paraíso do Tocantins 1
Perth 1
Phoenix 1
Ramallah 1
Redenção 1
San Jose 1
San Mateo 1
Santa Luzia 1
Saratov 1
Secaucus 1
Stockholm 1
São Paulo 1
Thái Bình 1
Toronto 1
Trieste 1
Vienna 1
Warren 1
Warsaw 1
Zapotlán el Grande 1
Totale 326
Nome #
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 45
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 41
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 41
Microstructural alterations of the spinothalamic tract and neuropathic pain: A diffusion tensor imaging study in relapsing remitting multiple sclerosis 40
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 37
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 35
PRECLINICAL MARKERS OF NEUROPATHIC DAMAGE IN TYPE 1 DIABETES MELLITUS 32
Two cases of unilateral wasting and weakness of distal upper limb: Similar onset and different diagnosis in young patients 32
Opicapone-induced reversible myopathy in a patient with advanced Parkinson’s disease and familial hyperCKemia 32
The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis 29
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 26
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 19
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 18
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 14
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 13
Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease 12
Totale 466
Categoria #
all - tutte 4.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 2 0 0 0 6 0 6 0 0
2021/202212 0 0 0 4 3 0 0 1 3 1 0 0
2022/202363 8 4 2 3 2 4 1 1 2 4 11 21
2023/202461 11 10 3 5 2 7 13 3 0 2 0 5
2024/2025154 15 1 0 6 16 17 8 8 27 6 20 30
2025/2026162 47 96 19 0 0 0 0 0 0 0 0 0
Totale 466